EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC

Yaoyao Zhou, Ziyun Liu, Parhat Kaysar, Yuxi Han, Yijian Ma, Xiaozhou Yu, Bo Ni, Zuoyu Chen, Yongjie Xie, Haoling Zhang, Yueguo Li

Journal for ImmunoTherapy of Cancer · 2026-09 · 14 (9) · e014772

DOI: 10.1136/jitc-2026-014772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 08.09.2026. Verfasst von Yaoyao Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laborat…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutrophils, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Postdoctoral Program for Innovative Talents, National Natural Science Foundation of China, Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-small cell lung cancer (NSCLC) is one of the frequently occurring cancers characterized by molecular heterogeneity and multiple immune cell infiltration patterns, which are associated with treatment sensitivity and resistance. However, the specific microenvironmental cells and their mechanisms that lead to treatment resistance in patients need to be explored in greater depth.

Methods

On the basis of patients receiving neoadjuvant therapy in our center, a multicenter, multicohort NSCLC spatial transcriptome, single-cell transcriptome, T-cell receptor repertoire sequencing, bulk RNA transcriptome, phosphorylated proteome, genome mutation, and clinical data were included for a comprehensive assessment of the therapeutic and prognostic impact of HIF1A + CSF3R + neutrophils in NSCLC. In vitro experiments validated the functional phenotype of HIF1A + CSF3R + neutrophils and co-localization interactions with other cellular subpopulations. Gradient boosting machine (GBM) constructed region of interest (ROI) models for evaluation. Computer-aided drug design (CADD) was used to predict targeted small molecule drugs, and in vivo mouse models were constructed to assess the effectiveness of the combination treatment regimen.

Results

Centered on HIF1A + CSF3R + neutrophils, recruited exhausted T cells and stromal cells form a hypoxic niche within the tumor region, which was enriched in non-response patients. ROI composed of these specific cellular subpopulations, associated with senescence and glycolysis, accurately predicting NSCLC progression, prognosis, and microenvironment composition. CADD analysis identified that platycodin-D2 specifically targeted CSF3R, reducing HIF1A expression and inhibiting neutrophil activity. Combining navitoclax, platycodin-D2 with anti-programmed cell death protein 1 (PD-1) significantly suppressed tumor proliferation and improved the immunosuppressive microenvironment.

Conclusion

Our study emphasized the role of HIF1A + CSF3R + neutrophils in immunotherapeutic resistance of NSCLC, constructed a microenvironmental immune dysregulation network in a hypoxic ecological niche with HIF1A + CSF3R + neutrophils as the center. Platycodin-D2 specifically targeted HIF1A + CSF3R + neutrophils, enhancing the efficacy of anti-PD-1 therapy in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeutrophilsNeoadjuvant TherapyHypoxia-Inducible Factor 1, alpha SubunitDrug Resistance, NeoplasmReceptors, Colony-Stimulating FactorHumansAnimalsMiceMetabolic ReprogrammingTumor MicroenvironmentFemale

Stichwörter der Autor:innen

NeutrophilNon-Small Cell Lung Cancer

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, humanCSF3R protein, humanReceptors, Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, State Key Laboratory of Druggability Evaluati…
  • Pancreas Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key L…
  • Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Department of Molecular Im…
  • Department of Minimally Invasive Esophageal Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Labor…
  • Department of Biomedical Sciences, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, 13200 Kepala Batas, State of Penang, Malaysia yli08@tmu.edu.cn zhanghaolingedu@163.com 2335940013@qq.com chenzuoyu24@…

Förderung

  • National Postdoctoral Program for Innovative Talents
  • National Natural Science Foundation of China
  • Postdoctoral Science Foundation

Zitieren

APA

Zhou, Y., Liu, Z., Kaysar, P., Han, Y., Ma, Y., Yu, X., Ni, B., Chen, Z., Xie, Y., Zhang, H., & Li, Y. (2026). HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. Journal for ImmunoTherapy of Cancer, 14(9), e014772. https://doi.org/10.1136/jitc-2026-014772

Vancouver

Zhou Y, Liu Z, Kaysar P, Han Y, Ma Y, Yu X, et al. HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC. Journal for ImmunoTherapy of Cancer. 2026;14(9):e014772. doi:10.1136/jitc-2026-014772

BibTeX
@article{Zhou2026,
  author = {Zhou, Yaoyao and Liu, Ziyun and Kaysar, Parhat and Han, Yuxi and Ma, Yijian and Yu, Xiaozhou and Ni, Bo and Chen, Zuoyu and Xie, Yongjie and Zhang, Haoling and Li, Yueguo},
  title = {HIF1A + CSF3R + neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {9},
  pages = {e014772},
  doi = {10.1136/jitc-2026-014772}
}
Kostenlos starten →